CG Oncology valued at $1.75 bln in strong market debut
25/01/2024 18:44
Jan 25 (Reuters) - CG Oncology CGON.O notched up a
valuation of $1.75 billion in its market debut on Thursday,
after shares of the cancer drug developer rose 52.6% at the open
on the Nasdaq.
(Reporting by Pritam Biswas in Bengaluru; Editing by Pooja
Desai and Shilpi Majumdar)
((Pritam.Biswas@thomsonreuters.com;))